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The.In Vivo Effect of Hepatotrophic Factors Augmenter of Liver 
Regeneration, Hepatocyte Growth Factor, and Insulin-Like 
Growth Factor-lIon Liver Natural Killer Cell Functions 
ANTONIO FRANCAVILLA,1.3 NIKOLA L. VUJANOVIC,2 LORENZO POLIMENo,l·3 ALESSANDRO AzZARONE/·3 
ANGELO IACOBELLIS,1.3 ALBERT DELEO,2 MICHIO HAGIYA,4 THERESA L. WHITESIDE,2 AND THOMAS E. STARZL1 
Fine balanced sequential changes of the levels of cir-
culating hepatotrophic factors are' essential for normal 
liver regeneration. Our recent studies have indicated 
that liver-resident natural killer (NK) cells are im-
portant regulators of liver regeneration and have raised 
the possibility that hepatotrophic factors might mediate 
their activities through NK cells. In the present study, 
we assessed the effects of in vivo administration of three 
hepatotrophic factors (augmenter of liver regeneration 
[ALR], insulin-like growth factor-IT [lGF-IT], and hepato-
cyte growth factor [HGF]) on NK cells in normal rats. 
Each of the three, given over a I-day period in doses 
known to produce hepatotrophic activity, induced inhi-
bition of NK cell cytotoxic activities in the population of 
mononuclear leukocytes CMNL) in the liver, but not in 
MNL from the spleen or peripheral blood. In contrast to 
these results obtained by the whole animal treatment, 
the three molecules had no effect on NK cell functions 
when added to cultures of MNL from the livers, spleens, 
or blood of untreated rats. These data support and ex-
tend our previously advanced hypothesis that ALR and 
other hepatotrophic factors play an important role in 
liver regeneration by regional regulation of NK cells 
through some as-yet-unknown intermediary mecha-
nism. (HEPATOLOGY 1997;25:411-415.) 
Hepatotrophic factors (Table 1) have been so character-
ized 1-15 by virtue of their ability to augment the hyperprolifer-
ative response induced by partial hepatectomy (PH) in rats3•6 
or dogs,5 and to prevent the atrophy as well as augment the 
heightened cell renewal caused by portacaval shunt (Eck's 
fistula) in dogs. 2•4 Only two of the eight known hepatotrophic 
factors (hepatocyte growth factor [HGF] and transforming 
growth factor [TGF]-a) are primary mitogens capable of stim-
ulating de novo hepatocyte proliferation in vitro without the 
requisite precondition of preexisting commitment to height-
Abbreviations: PH, partial hepatectomy; HGF, hepatocyte growth factor; TGF, trans-
fonning growth factor; ALR, augmenter of liver regeneration; NK, natural killer; MNL, 
mononuclear leukocytes; IGF-II. insulin-like growth factor-II; Ig. immunoglobulin; NKR-
PI, natural killer receptor protein 1; mAbs, monoclonal antibodies; LV, lytic unit. 
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ened cell renewal. Molecules with opposite effects have been 
called "antihepatotrophic_,,16-18 
After PH, there is an acute temporary increase in the circu-
lating levels of several of the endogenous hepatotrophic fac-
tors1,2,4.5,19 and multiple gene expression in the liver.20 We 
have speculated that the hepatocyte stimulatory activity of 
augmenter of liver regeneration (ALR) and the other hepato-
trophic factors may be mediated through or by nonparenchy-
mal cells.1,9,21 This possibility was reinforced by the observa-
tion during the acute phase of regeneration after PH in rats 
of temporary suppression of natural killer (NK) cell functions 
of liver mononuclear leukocytes (MNL), followed by their re-
covery at the termination of regeneration.21 These changes 
occurred contemporaneously with mirror-image susceptibil-
ity of the regenerating hepatocytes to NK-induced lysis. 
To test this immunologic hypothesis, we have determined 
in the present study whether the changes ofNK cell function 
occurring after PH could be reproduced in unoperated naive 
rats by their treatment with three potent recombinant hepa-
totrophic factors chosen from the list in Table 1: IGF-II, HGF, 
and ALR All three of these systemically administered growth 
factors were found to mimic all of the changes of spontaneous 
NK cell functions associated with PH, including the limita-
tion of their effect to liver mononuclear leukocytes (MNL). 
Because these factors had no effect on cultures ofliver MNL 
from naive rats, additional unknown extra- or intrahepatic 
mediator(s) may be involved in their hepatic growth regula-
tion_ 
MATERIALS AND METHODS 
Materials and Assays 
Animals_ Male Fischer F344 rats (180-200 g) were purchased from 
Hilltop Lab Animals, Inc. (Scottdale, PAl, and were housed in a 
specific pathogen-free animal facility of the Pittsburgh Cancer Insti-
tute for at least 20 days before the experiments and were fed with 
standard rat chow and water ad libitum. 
Antibodies and Reagents. For phenotyping of rat MNLs, fluores-
cein isothiocyanate-Iabeled mouse monoclonal antibodies to rat 
T-Iymphocyte surface antigens including anti-CD5 (OXI9, immuno-
globulin [IglGI) from Accurate Chemical and Scientific Corp. (West-
bury, NY), and CD3 (G.4.l.A., IgG3) from Bioproducts for Science 
(Indianapolis, IN) were purchased_ Monoclonal antibody against 
NKR-Pl (3,2_3, IgGl) was raised and conjugated with fluorescein 
isothiocyanate in our laboratory for the identification of NK cells. 
IgG isotope control antibodies were purchased from Becton Dickinson 
(San Jose, CA)_ 
Rat recombinant (rlALR expressed in transfected COS-l cells9 and 
rHGF were gifts from Toyobo Co., Ltd. (Ohtsu, Shiga, Japanl, while 
rIGF-II was purchased from United States Biochemical (Cleveland, Om. 
Isolation of Rat MNL. Liver, spleen, and blood MNL were isolated 
and purified, as previously described. 21 Briefly, liver-resident MNL 
were isolated, after enzymatic digestion ofliver tissue, using metriza-
mide and Ficoll-Hypaque density gradient centrifugations. MNL 
from blood and spleen were separated using Ficoll-Hypaque density 
gradient centrifugations. 
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TABLE. 1. Growth Factors Revealed by Studies 
In Eck Fistula Models (1995) 
Growth Factors 
Stimulatory 
Hormones: 
Insulin 
Growth Factors: 
Cytosol protein fractions or ALR 
IGF·II 
TGF-", * 
HGF* 
Immunosuppressants 
Cyciosporine 
FK506 
Immunophilins 
FKBP12 
Inhibitory 
Growth factors: 
TGF-,Bt 
Immunosuppressants 
Rapamycint 
* Mitogenic in tissue culture. 
t Inhibitory in tissue culture. 
Reference 
Starzl' 
Francavilla!.""; Starzl"'; LaBreque3; 
Terblanche5; Hagiya9 
Francavilla 10 
Francavilla 10 
Francavilla 10 
Makowkal1 ; Mazzaferro12 
Francavilla 13: StarzP' 
Starz]15 
Francavilla I"; Braun 1 7 
Francavilla 18 
Immunofluorescent Staining and Flow Cytometry of MNL. The 
MNL were adjusted to a concentration of 0.25 X 106/0.2 mL in phos-
phate-buffered saline containing 0.1% (wtlvoll sodium azide and 1% 
fetal bovine serum (vol/vol). For direct single-color immunofluores-
cent staining, the cells were mixed with fluorescein isothiocyanate-
labeled mAbs. Cells suspended in phosphate-buffered saline-azide 
buffer alone or in fluorescein isothiocyanate-conjugated IgG 1 mono-
clonal antibodies (mAb) were used as negative controls. After incuba-
tion with the mAbs or reagents at 4°C for 30 minutes, the cells 
were washed two times with phosphate-buffered saline- azide buffer, 
resuspended in 1% (wtlvoll paraformaldehyde, and examined by sin-
gle-color flow cytometry on a FACScan.21 Data were analyzed using 
the Reproman computer program (Flow Cytometry Analysis Soft-
ware for Personal Computers, True Facts Software Inc., Seattle, 
WA). 
Cytotoxicity Assays 
A standard 4-hour slCr-release microcytotoxicity assay was used 
to quantitate direct cytolytic activity against the NK-sensitive YAC-
1 lymphoma cells and NK-resistant P815 mastocytoma cells, as pre-
viously described. 21 
Antibody-Dependent Cellular Cytotoxicity. After 51Cr-Iabeling, P815 
target cells were preincubated for 15 minutes at room temperature with 
rat anti-P815 antiserum (a gift of Dr. W.H. Chambers) at a subaggluti-
nating concentration, washed twice, and mixed with the MNL. 
Redirected Killing Via NKR·Pl. MNL were preincubated with 
anti-natural killer receptor protein 1 (NKR-PIJ mAb (0.1 !Lg/mL) at 
room temperature for 15 minutes. This procedure resulted in sensiti-
zation of NK cells in the population of MNL, as a consequence of the 
specific binding of this mAb to NKR-P1 receptor. The assay was 
continued by adding to the effector cells 5lCr-labeled P815 target 
cells, which express cell surface Fc receptors and are able to ligate 
the Fc portion of anti-NKR-P1 mAb bound to NK cells, and thus to 
cross-link the NKR-P1 receptor, triggering cytolytic activity of NK 
cells."" P8I5 cells preincubated with rat serum obtained before im-
munization or with a nonreactive IgG I mAb served as negative con-
trol targets to antibody-dependent cellular cytotoxicity or redirected 
killing, respectively. Spontaneous release and maximum release 
were determined by incubating target cells without effectors in me-
dium alone or in 5% Triton X-lOO, respectively. The spontaneous 
release was less than 10'11- for both YAC-1 and P8I5 target cells. 
All of the foregoing assays were performed in triplicate. Radioac-
tivity was counted in a gamma counter, and the percentage ofspecitic 
lysis was determined according to the formula: 
r; specific lysis 
I mean rpm experimental J'elease - mean cpm spontaneous release I . 1110 
I mean cpm maximal release - mean cpm spontaneous releast' j 
HEPATOLOGY February 1997 
Lytic units (LU) wer(J calculated using a computer program devel-
oped by Pross et a1.23 One lytic unit was defined as the number of 
effector cells needed to lyse 20% of 5 x 103 target cells. LU per 107 
effector cells were calculated on the basis of the following formula: 
LU,oI107 MNL x 10 
% NKR_P1bnghtMNL 0 
Experimental Design 
In Vivo Effect of Hepatotrophic Factors on NK Cell Functions of 
Normal Nonoperated Rats. Four doses of 125 ng rALR or rIGF-II 
were injected intramuscularly and four doses of 1,000 ng rHGF were 
given intravenously at 24, 18, 12, and 6 hours before the animals 
were killed. The animals were killed, and MNL were isolated from 
peripheral blood, spleen, and liver. The phenotype and cytotoxic ac-
tivities of MNL were determined. 
In Vitro Effects of Growth Factors on NK Cells in MNL Popula-
tions. Suspensions of MNL isolated from the blood, spleen, and liver 
of normal rats were prepared in culture medium (RPMI 1640 plus 
10% fetal bovine serum), which was supplemented with hepato-
trophic factors rALR, rIGF-II, and rHGF singly or in combination. 
The cells were either assessed immediately or after 24 hours of cul-
ture at 37°C. Their cytotoxic activity was tested in the assays de-
scribed above. 
Statistical Analysis 
Statistical significance of the results was calculated using Wil-
coxon's signed rank pair and Mann-Whitney U tests. Differences 
were considered significant at P < .05. 
RESULTS 
Systemic Administration of Hepatotrophic Factors 
Composition of MNL in the Liver and Peripheral Lymphoid 
Tissues. The percentages ofNKR-Pl bright (NK) cells and CD5+ 
or CD3+ (T) lymphocytes in the liver, spleen, or blood of rats 
after administration of any of the hepatotrophic factors were 
not different from the saline controls (Table 2). The failure 
of treatment to influence changes of the proportions of MNL 
subpopulations, either in the liver or in the peripheral 
lymphoid tissues was similar to that after PH.21 
NK Cell Functions. In contrast to the unchanged pheno-
type, the rALR, rHGF, and rIGF-II had significant and multi-
ple suppressive effects on various NK cell functions (Table 
TABLE 2. Phenotype of Liver, Spleen, and Blood MNL Obtained From 
Rats Following 24-Hour Treatment With Hepatotrophic Factors 
Source of MNL CD5' (T) Cells NKR-Pl bri" ... (NK) Cells 
Liver 
Vehicle (control) 25:!: 11 34:!: 9 
ALR 23 :!: 8 33:!: 10 
IGF-II 25:!: 7 32:!: 11 
HGF 28:!: 9 31 :!: 8 
Spleen 
Vehicle (controll 57:!: 8 8:!:2 
ALR 52:!: 5 10 :!: 1 
IGF-II 55:!: 4 9 :!: 2 
HGF 56:!: 4 11 :!: 2 
Blood 
Vehicle (control I 85 :!: 4 6:!: 9 
ALR 77 :!: 6 13 :!: 7 
lGF-II 88 :!: 7 9:!:4 
HGF 83 :!: 5 12 :!: 3 
;-.IOTE. Data are means:!: SEM of percentages of total MNL in liver, spleen. 
and blood cells. Flow cytometry analysis of MNL was performed after immuno-
staining with fluorescein isothiocyanate-Iabeled anti-CD5. anti-CD3 (data not 
shown. similar to that obtained with anti-CD51 01' anti-NKR-P1 mAbs. as 
described in Materials and Methods. Three animals contributed to each experi-
Illt'nl. rALR 01' .-1GF-II 10.5 Ii!':! and rHGF 14.0 Ilg1 were the total doses of the 
gl'()\\,th t~llDiEFfDp illjiDctl~d pL'r individual animal during 24 hours. 
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3). The 24-hour pretreatment of normal rats with either of 
the three hepatotrophic factors induced a rapid suppression 
of all of the tested spontaneous NK cell functions in liver-
resident MNL, including direct killing of YAC-l and P815 
target cells, as well as indirect killing, such as antibody-de-
pendent cellular cytotoxicity and NKR-Pl-mediated redi-
rected lysis of P815 target cells (Table 3). However, while 
ALR and IGF-II showed consistent suppressive effects in all 
experiments performed, as well as in a variety of assays uti-
lized, HGF showed some inconsistency of activity, inducing 
in one of the experiments a stimulation of NK cytotoxicity 
against YAC-l targets and a suppression of spontaneous lym-
phocyte-activated killing againstP815 tumor cells (Table 3). 
In addition, combined treatment with three hepatotrophic 
factors showed an inconsistency of effects on liver-resident 
NK cells similar to HGF alone (Table 3). These data suggest 
that HGF may partially differ from ALR and IGF -II in mecha-
nisms of in vivo induction of functional modulation of liver-
resident NK cells, and that, in combined treatment, its effect 
is dominant. 
Neither rALR, rHGF, nor rIGF-II had a significant effect 
on spleen or blood NK cell killing activities (data not shown). 
In Vitro Effects of Hepatotrophic Factors 
on NK Cell Functions 
To define whether hepatotrophic factor-induced changes 
in liver-resident NK cells are a consequence of a direct or 
TABLE 3. In Vivo Effects of rALR, rHGF, and rIGF-1I on Cytolytic 
Functions of Liver-Resident NK Cells 
Effectors Target. (Cytotoxicity) 
Experiment 1 
Vehicle (Controll YAC-1 (NK) 
ALR 
HGF 
IGF-II 
Vehicle (contrail P815 (LAK) 
ALR 
HGF 
IGF-II 
Vehicle (controll 
ALR 
HGF 
IGF-II 
PS15 + aPS15 Abs 
(ADCC) 
Vehicle (contrail PS15 + aNKR-Pl mAb 
ALR (redirected) 
HGF 
IGF-ll 
Experiment 2 
Vehicle (contrail YAC-1 lNK) 
ALR 
HGF 
IGF-II 
ALR + HGF + 
IGF-II 
Vehicle (contrull 
ALR 
lGF-II 
HGF 
ALR + HGF + 
IGF-ll 
P815 (LAK) 
LU..,IIO'NK % Modulation 
193.3 0 
125.3 -35 
140.2 -27 
115.1 -40 
15.4 0 
9.9 -36 
6.2 -60 
4.3 -70 
376.0 0 
261.6 -29 
237.4 -35 
138.1 -62 
48.3 0 
44.2 -9 
28.6 -40 
36.7 -24 
501.6 0 
333.1 -34 
574.8 +15 
418.5 -17 
606.5 +20 
53.8 0 
26.1 -45 
31.6 -41 
37.6 -:30 
41.1 -24 
NOTE. Liver-resident MNL were isolated from vehicle I control 1-. rALR-. 
rHGF-. 01' rIGF-I1-treated animals for 24 hours and were assessed for their 
cytotoxicity using- various assays. as described in Materials and Methods. Data 
represent LU,,/lO' NK cells calculated on the basis of the triplicate mean 
percentag-es of MNL killing in four different effector:target rntios. and the 
percentage of NKR_PI'n''''H INK) cells. determined by now cytometry." Results 
are from two experiments (n = ;) per group J. 
Abbreviations: L\K. Iymphocyte-actlvated killer: ADCC. antibody-depen-
dent cellular e~DtotoxicltvK 
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TABLE 4. Changes of Spontaneous NK Cell Functions Following PH 
or Hepatotrophic Factor Treatment in Rats 
Following Following Hepatotrophic 
PH Factors 
Cell Functions 3 h to 14 d 24 hln Vi"o In Vitro 
YAC-llysis OF OF NC 
PS15 lysis DF OF NC 
ADCC OF OF NC 
Redirected lysis OF OF NC 
NOTE. The summary of PH effects is from our previous publication21 and 
that after treatments with hepatotrophic factors from the present study. 
Abbreviations: OF, decrease of function; NC, no change of function; ADCC, 
antibody-dependent cellular cytotoxicity. 
indirect effect, we added rALR, rHGF, or rIGF-II to cultures 
ofMNL isolated from the livers of untreated rats. The addi-
tion of the hepatotrophic factors during the 4-hour 5ICr_re_ 
lease cytotoxicity assays did not change spontaneous NK, 
lymphocyte-activated killer, and antibody-dependent cellular 
cytotoxicity cytolytic functions or redirected killing (data not 
shown). Similar data were obtained when liver-resident MNL 
were preincubated for 24 hours in the presence of any of these 
hepatotrophic factors (data not shown). 
DISCUSSION 
Liver regeneration following a PH of 70% is associated with 
an increase in serum levels of ALRI and other growth factors, 
including HGF, TGF-a, and epidermal growth factors,19.24 
which peak in 12 hours and return almost to baseline by 
24 hours. During approximately the same time, rapid and 
profound suppression of a variety of spontaneous functions 
of liver-resident NK cells has been shown.21 In the present 
study, we showed that the treatment of normal nonoperated 
rats for 24 hours with exogenous rALR, rHGF, and rIGF-I1 
caused the same liver-restricted changes in NK cell function 
(Table 4). 
The molecules listed in Table 1 prevent in vivo hepatocyte 
atrophy as well as dramatically up-regulate hepatocyte re-
newal. For their full expression of a proliferative effect on 
hepatocytes, these hepatotrophic factors, including that of 
HGF and TGF-a (which also are considered primary initia-
tors of mitosis in vitro24•25 ), require the prior, independent 
establishment of hyperplasia above resting baseline levels.2-6.1o 
Recognition of the necessity for a priming stimulus underlies 
the delineation with the Eck fistula2•4•10 and minimum hepa-
tectomy models3.5.6 used to delineate the major hepatotrophic 
molecules listed in Table 1. Webber, Godowski, and Fausto26 
associated the liver priming produced with minimal (30%) 
hepatectomy with an increased expression of a variety of 
proto-oncogenes, including c-myc. 
The demonstrations that TGF-tJ was antihepatotrophic 
(causing atrophy and hypoplasia)1O·16.17 and that the serum 
levels ofthis cytokine correlated with the events of regenera-
tion172!i.27 raised the possibility that TGF-tJ was the turn-off 
switch that terminated liver volume restoration. The hypoth-
esis that emerged from this collective body of work was that 
liver growth is regulated by an inter-reactive network of the 
various autocrine. paracrine. and endocrine factorsKlKl~g 
Another i and not mutually exclusive) theory is that organ 
growth is regulated by the immune systemK~1KOU-:jig This hy-
pothesis was strengthened when the T-cell-directed immu-
nosuppressants, tGcrolimus and cyclosporine, 11-14 which dis-
rupt signal transduction from the T-cell receptor to the 
nucleus. as well as the recombinant cytosolic binding protein 
of tacrolimus I FKBP12 I. (-, were shown to be potently hepato-
trophic. Howl'ver. the credibility of this hypothesis lost 
ground wlwn rapanwcin. which also is T-cell inhibitory but 
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by a more distal molecular site of action (proximal to the 
ribosomes), was shown to be potently antihepatotrophic. 18 
Confusing the issue further, T-cell-deficient (nude) rats 
whith have normal liver regeneration following PH, had aug-
mentation of this response by tacrolimus treatment to the 
same extent as immunologically intact animals.31 Because 
tacrolimus has no effect on the function of isolated spleen 
NK cells from norma131,32 or nude rats both in vivo and in 
vitro,31 the hypothesis by Itoh et a1.30 that NK cells capped 
the magnitude of hepatic regeneration was initially dis-
counted by US.31 However, in our earlier nude rat studies, 
the NK cell functions were determined in leukocytes isolated 
from peripheral lymphoid tiss.ues (i.e., spleen), not from the 
liver. 31 
Our recently published investigations in normal rats fol-
lowing PH of 70%21 have provided strong evidence that liver-
resident (but not peripheral lymphoid organ) NK cells do in 
fact undergo sequential functionai changes (see Table 4), and 
are potentially involved not only in the termination of regen-
eration, as postulated by Itoh et a1.,30 but also in its initiation. 
The in vivo depletion ofNK cells before PH significantly aug-
mented liver regeneration in normal rats.21 These data and 
those reported herein are compatible with the hypothesis that 
ALR, HGF, IGF-II, and presumably other hepatotrophic fac-
tors produced at the earliest post-PH stage ofliver regenera-
tion, are associated with, and may be at least partially re-
sponsible for the local suppression of liver-resident NK cells. 
This would allow conversion of the quiescent normal liver to 
the state of regeneration. 
Interestingly, tl~e joint administration of ALR, HGF, and 
IGF-II to intact animals did not produce the expected syner-
gistic suppressive effect on liver NK cells. The modulation of 
NK cell functions after combined treatment was similar to 
that obtained with HGF alone. This finding suggests that 
simultaneous administration ofhepatotrophic factors in opti-
mal doses resulted in competition rather than in synergism. 
It is possible that, to obtain synergy, it would be necessary 
to use their sequential administration and different (perhaps 
smaller) doses than we used. Because hepatotrophic factors 
showed suppressive effects on NK cells only in vivo and only 
in the liver, it is conceivable that they indirectly suppress 
liver NK cells in intact animals by inducing the production 
of a suppressive factor by cells not present in the purified 
populations ofliver-derived MNL. Congruent with this possi-
bility, it has been shown that ALR33 as well as IGF_II34.35 
selectively accumulate in liver sinusoids and possibly bind to 
the sinusoid lining (endothelial) celis, which also represent 
the major cells in the liver interacting with and binding liver-
resident NK cells. In addition, liver sinusoid endothelial cells 
have been shown during post-PH liver regeneration to be 
early producers ofTGF-,B, 17 a powerful antihepatotrophic and 
immunosuppressive cytokine.16,17.26 Thus, ALR as well as 
other hepatotrophic factors may exercise their suppressive 
effect on NK cells by binding to and inducing liver sinusoid 
endothelial cells to produce TGF-,B. The implication is that 
hepatotrophic and antihepatotrophic factors (see Table 1) 
have a complex, coordinated, physiological effect. 
Mesenchymal-epithelial interactions have been proposed 
as the essential governance mechanism of embryonal organ 
morphogenesis, epithelial differentiation, and tissue remod-
elling, of which hepatic regeneration is a prime example in 
mature mammals. Such speculation is supported by circum-
stantial evidence from tissue culture technology36 and more 
recently from molecular studies ofHGF (scatter factor).:!? Re-
generation responses, including those following unilateral 
duct ligation and meI:g~ could be explained most easily by 
endocrine communication or, alternatively, by the migration 
and in situ activity of variolls hematolymphopoietic cell lin-
eages. including NK cells.:!uH.4o 
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